Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kyowa Kirin, Inc. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Observational study comprising prospective follow up as well as retrospective chart review in order to evaluate the longitudinal course of the disease in XLH patients with a specific focus on functional impairment, physical performance and complications associated with the disease or respective treatment.
This is an observational / non-interventional study in order to assess the longitudinal course of XLH including disease related burden of disease and functional impairment. This is accomplished by both prospective follow up of affected patients as well as retrospective chart review. Evaluation conducted as per clincal routine and specifically evaluated as part of this study will include
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| no intervention | Other | no intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Course of disease | To document and assess the natural course of disease, associated symptoms and functional impairment in adult patients with XLH. | retrospective and up to 48 months from enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Comorbidities and medical treatment | Assess and document comorbidities and medical treatment regimens applied in adult patients with XLH | retrospective and up to 48 months from enrollment |
| Functional deficits and mobility constraints |
| Measure | Description | Time Frame |
|---|---|---|
| Impact of treatment on physical performance | Evaluate the impact of clinical routine treatment including both medical approaches and physical therapy on physical performance and mobility of adult patients with XLH | retrospective and up to 48 months from enrollment |
| Medical history |
Inclusion Criteria:
Male or female, aged ≥ 18 years, inclusive, at the time of enrollment
Diagnosis of X-linked Hypophosphatemia confirmed by
Written informed consent
Exclusion Criteria:
- Suspected of confirmed diagnosis of another phosphate wasting disorder
Not provided
Not provided
Not provided
Not provided
Adult patients with X-linked Hypophosphatemia
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Orthopedic Center for Musculoskeletal Research, Orthopedic Department, University of Wuerzburg | Würzburg | 97074 | Germany |
Individual participant data cannot be shared in order to warrant patients privacy.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D053098 | Familial Hypophosphatemic Rickets |
| ID | Term |
|---|---|
| D063730 | Rickets, Hypophosphatemic |
| D012279 | Rickets |
| D001851 | Bone Diseases, Metabolic |
| D001847 | Bone Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Serum / Plasma / Urine
Assess and document functional deficits and mobility constraints in adult patients with XLH
| retrospective and up to 48 months from enrollment |
| Laboratory values | Assess laboratory parameters over time in adults with XLH | retrospective and up to 48 months from enrollment |
| Organ / tissue specific health issues | Describe frequency and outcome of organ / tissue specific health issues (affecting e.g. skeleton, dental health, muscles and joints) in adults with XLH | retrospective and up to 48 months from enrollment |
| Safety and tolerability of treatment | Evaluate safety and tolerability of various treatment regimens commonly applied in XLH patients | retrospective and up to 48 months from enrollment |
| Quality of life | Assess quality of life and respective determining factors in adults patients with XLH | retrospective and up to 48 months from enrollment |
Document and assess medical history of adult patients with XLH in order to understand its predictive value on burden of disease in adulthood |
| retrospective and up to 48 months from enrollment |
| D009140 |
| Musculoskeletal Diseases |
| D007015 | Hypophosphatemia, Familial |
| D015499 | Renal Tubular Transport, Inborn Errors |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D008664 | Metal Metabolism, Inborn Errors |
| D008661 | Metabolism, Inborn Errors |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D002128 | Calcium Metabolism Disorders |
| D017674 | Hypophosphatemia |
| D010760 | Phosphorus Metabolism Disorders |
| D014808 | Vitamin D Deficiency |
| D001361 | Avitaminosis |
| D003677 | Deficiency Diseases |
| D044342 | Malnutrition |
| D009748 | Nutrition Disorders |